Thursday, April 17, 2008:
Long-Term Safety of DES in Off-Label Use: Results of the MATRIX Registry
by Dr. George D. Dangas
Thursday, April 17, 2008:
Impact of clopidogrel loading dose on the safety and effectiveness of
bivalirudin in patients undergoing primary angioplasty for acute
myocardial infarction: The HORIZONS AMI Trial by Dr. George D.
Dangas
Thursday, April 17, 2008:
Impact Of Diabetes Mellitus On The Safety And Effectiveness Of
Bivalirudin In Patients With Acute Myocardial Infarction Undergoing
Primary Angioplasty: The HORIZONS AMI Trial by Dr. Bernhard
Witzenbichler
Thursday, April 17, 2008:
Impact of gender on the safety and effectiveness of bivalirudin in
patients with acute myocardial infarction undergoing primary
angioplasty: The Horizons AMI Trial by Dr. L. Grinfield
Thursday, April 17, 2008:
Impact of Baseline Renal Function on the Safety and Effectiveness of
Bivalirudin in Patients with Acute MI Undergoing Primary Angioplasty:
The HORIZONS AMI Trial by Dr. Roxana Mehran
Thursday, April 17, 2008:
Impact of advanced age on the safety and effectiveness of bivalirudin in
patients with acute myocardial infarction undergoing primary
angioplasty: The HORIZONS AMI Trial by Dr. Dariusz Dudek
Thursday, April 17, 2008:
Major Adverse Events in STEMI Patients Treated with Primary Angioplasty
Occur More Frequently at U.S. Compared with Non U.S. Sites: Analysis
from the HORIZONS AMI Trial by Dr. Bruce R. Brodie
Thursday, April 17, 2008:
Safety and effectiveness of bivalirudin compared to either abciximab or
eptifibatide in patients with acute myocardial infarction undergoing
primary angioplasty: The HORIZONS AMI Trial by Dr. Giulio Guagliumi
Monday, April 7, 2008:
Trends in the Quality of Care of Patients with Acute Myocardial
Infarction: The National Registry of Myocardial Infarction from 1990 to
2006 by Dr. Bimal R. Shah
Monday, April 7, 2008:
Bridging Oral Anticoagulation with Low Molecular Weight Heparin:
Experience in 367 Patients with Renal Insufficiency by Dr. Christoph
Hammerstingl
Friday, April 4, 2008:
Results of the Home
Automated External Defibrillator Trial: HAT Trial by Dr. Gust H.
Bardy
Thursday, April 3, 2008:
Ongoing-Tirofiban In Myocardial Infarction Evaluation: ON-TIME-2 by
Dr. Christian W. Hamm
Wednesday, April 2, 2008:
REsynchronization reVErses Remodeling in Systolic left vEntricular
dysfunction: Results of the REVERSE Trial by Dr. Cecilia Linde
Wednesday, April 2, 2008:
Long-term Cardiac Arrhythmias recorded by Insertable Loop Recorders in
Patients with depressed Left Ventricular Function after Acute Myocardial
Infarction: CARISMA by Dr. PE Bloch
Thomsen
Wednesday, April 2, 2008:
Effect of Rimonabant on Progression of Atherosclerosis in Patients with
Abdominal Obesity and Coronary Artery Disease: STRADIVARIUS by Dr.
Steven E. Nissen
Wednesday, April 2, 2008:
Is There a Critical Value of Daily Atrial Tachyarrhythmia Burden from
Device Diagnostics that Raises Stroke Risk? The TRENDS Study by
Dr.Taya V. Glotzer
Wednesday, April 2, 2008:
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to
Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing
High-Risk Coronary Artery Bypass Graft Surgery: Main Results of the
MEND-CABG II Trial by Dr. John H. Alexander
Wednesday, April 2, 2008:
The Safety and
Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) using an
Injection Catheter Trial: SEISMIC Trial by Dr. Patrick W. Serruys
Tuesday, April 1, 2008:
Anemia Is
Associated With Increased One-Year Mortality and Ischemic Events in
Patients With ACS: Results From the ACUITY Trial by Dr.
Steven V. Manoukian
Tuesday, April 1, 2008:Major
Bleeding Is Associated With Increased One-Year Mortality and Ischemic
Events in Patients With ACS: Results From the ACUITY Trial by Dr.
Steven V. Manoukian
Tuesday, April 1, 2008:
Transfusion is Associated With Increased One-Year Mortality and Ischemic
Events in Patients With ACS: Results from the ACUITY Trial by Dr.
Steven V. Manoukian
Tuesday, April 1, 2008:
Percutaneous Mitral Repair with the MitraClip® Device for Functional
Mitral Regurgitation: Results from the EVEREST Study by Dr. James
Hermiller
Tuesday, April 1, 2008:
Ensure’s Vascular Closure Device Speeds Hemostasis: ECLIPSE Trial by
Dr. S. Chiu Wong
Tuesday, April 1, 2008:
COntrast media and NephroToxicitr following coronary Revascularization
by AngioplaSTy: CONTRAST by Dr. Rainer Wessely
Tuesday, April 1, 2008:
Prospective, multicenter, randomized, double blind trial investigating
influence on PCI outcome of additional 600 mg clopidogrel load in
patients on chronic therapy: ARMYDA-Reload by Dr. Germano Di
Sciascio
Tuesday, April 1, 2008:
UK
Multi-Centre Trial In Atherosclerotic Renovascular Disease: ASTRAL Trial
by Dr. Philip A. Kalra
Monday, March 31, 2008:
Comparison of Pioglitazone vs. Glimepiride on Progression of Coronary
Atherosclerosis in Patients with Type 2 Diabetes: PERISCOPE Trial by
Dr. Steven E. Nissen
Monday, March 31, 2008:
Avoiding Cardiovascular Events through COMbination Therapy in Patients
LIving with Systolic Hypertension: The ACCOMPLISH Trial
Monday, March 31, 2008:
ONTARGET: The ONgoing Telmisartan Alone and in combination with Ramipril
Global Endpoint Trial by Salim Yusuf
Monday, March 31, 2008:
The Astroid Trial: A Study to Evaluate the Effect of Rosuvastatin on
Intravascular Ultrasound-Derived Coronary Atheroma Burden by
Dr. Christie M. Ballantyne
Monday, March 31, 2008:
The Hypertension
in the Very Elderly Trial (HYVET) by Dr. Nigel S. Beckett
Monday, March 31, 2008:
Stents
versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery
Disease: MAIN-COMPARE Study by Dr. Seung-Jung Park
Monday, March 31, 2008:
Paclitaxel-Eluting PTCA-Balloon Catheter
in Coronary Artery Disease: PEPCAD II ISR Study by Dr. Martin
Unverdorben
Monday, March 31, 2008:
Long-Term
Safety of DES in Off-Label Use: Results of the MATRIX Registry by
Dr. George D. Dangas
Monday, March 31, 2008:
A
Randomized, Multi-center Study of the Pimecrolimus-Eluting and
Paclitaxel-ElutinGCoronary Stent System in PatiENtswith De Novo
LEsionSof the Native Coronary ArterIeS: The Genesis Trial by Dr.
Stefan Verheye
Monday, March 31, 2008:
CREATE
Multi-Center Clinical Registry 9-month Angiographic and 12-month
Clinical Results by Dr. Yaling Han
Sunday, March 30, 2008:
Thrombus
Aspiration during Percutaneous coronary intervention in Acute myocardial
infarction Study: TAPAS by Dr. Felix Zijlstra
Sunday, March 30, 2008:
MULTIcentre evaluation of Single high-dose bolus TiRofiban versus
Abciximab with sirolimus eluting sTEnt or bare metal stent in acute
myocardial infarction studY: MULTISTRATEGY by Dr. Marco Valgimigli
Sunday, March 30, 2008:
Drug-Eluting
and Bare Metal Stenting for Acute Myocardial Infarction in Massachusetts
by Dr. Lauri Mauri
Sunday, March 30, 2008:
Abciximab in Patients with AMI Undergoing Primary PCI After Clopidogrel
Pretreatment: BRAVE-3 Trial by Dr. Julinda Mehilli
Sunday, March 30, 2008:
Vascular
Protection in High-Risk Non-ST Elevation Acute Coronary Syndromes:
Angioplasty Balloon-associated Coronary Debris and the EZ FilterWire
by Dr. Mark Webster
Saturday, March 29, 2008:
Comprehensive Meta-Analysis of DES vs. BMS Randomized Trials and
Registries by Dr. Ajay J. Kirtane
Saturday, March 29, 2008:
Bivalirudin Versus Unfractionated Heparin in Biomarker Negative Patients
With Stable and Unstable Angina Undergoing PCI: ISAR-REACT 3 by Dr.
Adnan Kastrati
Saturday, March 29, 2008:
Eight Months
Angiographic Follow-up in Patients Randomized to Crush or Culotte
Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation
Stent Technique Study by Dr. Pål Gunnes
Saturday, March 29, 2008:
Long-Term
Clinical Outcome After First Definite Stent Thrombosis: Dutch Stent
Thrombosis Registry by Dr. J.W. van Werkum
Saturday, March 29, 2008:
Percutaneous Coronary Interventions in Facilities without On-Site
Cardiac Surgery: A Report from the National Cardiovascular Data Registry
(NCDR)
Saturday, March 29, 2008:
Prasugrel Compared to Clopidogrel in Patients with Acute Coronary
Syndromes Undergoing PCI with Stenting: the TRITON - TIMI 38 Stent
Analysis by Dr. Stephen D. Wiviott
Saturday, March 29, 2008:
Adjusted Clopidogrel Loading Doses According to VASP Phosphorylation
Index Decrease Rate of Major Adverse Cardiovascular Events in Patients
With Clopidogrel low response: A Multicentre Randomized Prospective
Study by Dr. Laurent Bonello
Friday, March 28, 2008:
Comprehensive Meta-Analysis of DES vs. BMS Randomized Trials and
Registries by Ajay J. Kirtane, M.D., S.M. and Gregg W. Stone, M.D.
Monday, March 17, 2008:
Statistics for the Interventionalist by Dr. Gregory J. Dehmer
Tuesday, March 11, 2008:
The Total Artificial Heart:An Evolving Role in the Management of
End-Stage Heart Failure by Dr. Marvin J. Slepian
Monday, March 3, 2008:
In-stent Restenosis and Late Stent Thrombosis by Dr. Roxana Mehran
Wednesday, February 27, 2008:
Contrast Induced Nephropathy: Predictors, Prevention, and Management
by Dr. Roxana Mehran
Friday, February 22, 2008:
Hemodynamics for the Interventional Cardiologist by Dr. Gregory
Dehmer
Thursday, February 14, 2008:
Update on Novel Antiplatelet Agents Under Advanced Clinical Development
by Dominick J. Angiolillo, MD, PhD, FACC, FESC
Thursday, February 14, 2008:
A
Randomized Study Assessing the Impact of Cilostazol on Platelet Function
Profiles in Patients with Diabetes Mellitus and Coronary Artery Disease
on Dual Antiplatelet Therapy: Results of the OPTIMUS-2 (Optimizing
anti-Platelet Therapy In diabetes MellitUS) Study by Dominick J.
Angiolillo, MD, PhD
Thursday, February 14, 2008:
Antiplatelet Resistance: What Does it Mean
and What Should/Can we do About it? by Dominick J. Angiolillo, MD,
PhD, FACC, FESC
Friday, December 7, 2007:
PRasugrel IN Comparison to Clopidogrel for Inhibition of PLatelet
Activation and AggrEgation Results from the PRINCIPLE - TIMI 44
Study
Friday, November 9, 2007:
Long
Term Clinical Outcomes Following Drug-Eluting and Bare Metal Stenting in
Massachusetts by Laura Mauri
Wednesday, November 7, 2007:
Impact of Thromboaspiration during Primary PCI on Microvascular Damage
and Infarct Size: Acute and Long term CE-MRI Evaluation Results from
the EXPIRA Trial by Gennaro Sardella
Wednesday, November 7, 2007:
A
Randomized Trial of Genotype-uided versus Standard Warfarin Dosing in
Patients Initiating Oral Anticoagulation Results from the Couma-Gen
Study by Jeffrey L. Anderson
Tuesday, November 6, 2007:
The
Resynchronization Therapy in Normal QRS (RethinQ) Study by John F.
Beshai
Monday, November 5, 2007:
Bivalirudin With and Without Eptifibatide for Elective Stenting: A
Pharmacodynamic Study of Platelet Reactivity in Relation to the
Occurrence of Periprocedural Myocardial Infarction Results from the
CLEAR PLATELETS-2 Study
Monday, November 5, 2007:
Results
of the RACE Project
BREAKING NEWS Sunday, November 4:
Results of the TRITON- TIMI 38 Trial
Results of the BRIEF-PCI Trial
by Anthony Fung
Pooled Analysis of Early and Late Safety of a Zotarolimus-Eluting Stent
Safety Results from the Endeavor by Laura Mauri
Results of the ARMYDA-5 Trial by Germano Di Sciascio
Results of the ARMYDA-4 Trial by Germano Di Sciascio
Evidence-Based Medicine Therapies in ACS: From Principles to
Practice by Magnus Ohman
A
Prospective, Randomized Trial of a Paclitaxel-Eluting Balloon in
In-Stent Restenosis 2-Year Results
from PACCOCATH ISR 1 and 2 by Bruno Scheller
TRA-PCI update on the new antiplatelet agents: PAR-1
inhibitors by David Moliterno
TAXUS ATLAS SMALL VESSEL and LONG LESION: First Report of
Nine-Month Clinical and Angiographic Results by Mark Turco
Clopidogrel Response Variability and Resistance by Paul Gurbel
Eric Peterson provides an update on the CRUSADE and ACTION
Registries
Benefits of aggressive lipid lowering before and after PCI and
reperfusion by M. Gibson
Prolonged Infusion of Clevidipine Results in Safe and
Predictable Blood Pressure Control in Patients with Acute Severe
Hypertension Results from the VELOCITY Trial
A Prospective, Randomized Comparison of Bivalirudin vs. Heparin
Plus Glycoprotein IIb/IIIa Inhibitors During Primary Angioplasty
in Acute Myocardial Infarction 30 Day Results of the
HORIZONS AMI Trial
Antiplatelet therapy for Reduction of MYocardial Damage during
Angioplasty Results of the ARMYDA-5 Study
Impact
of thrombectomy with EXPort catheter in Infarct Related Artery
on procedural and clinical outcome in patients with AMI
The EXPIRA Trial
Thromboaspiration in Acute ST-Elevation MI Improves Myocardial
Reperfusion EXPORT STUDY-First Report
A Prospective, Randomized Trial Comparing an Everolimus-Eluting
Stent and a Paclitaxel-Eluting Stent in Patients with Coronary
Artery Disease 1-Year Follow-Up and Subgroup Analysis for
the SPIRIT III trial
Rapamycin-Eluting Stents With Different Polymer Coating to
Reduce Restenosis ISAR-TEST 3 Randomized Trial
A Randomized Comparison of a Zotarolimus-Eluting Stent and a
Paclitaxel-Eluting Stent in Patients with Coronary Artery
Disease The ENDEAVOR 4 Trial
Randomized Comparison between Sirolimus
(Cypher)/Sirolimus-analogous (Xience; Promus) vs. Paclitaxel
(Taxus vs.Costar) Eluting Stents in Coronary Lesions: a Single
Center Experience The ABSOLUTE Trial
The European Randomized CoStar Trial: Cobalt-Chromium
Paclitaxel-eluting Stent vs. identical BMS Results of
the EuroSTAR II Trial
Antiplatelet therapy for Reduction of MYocardial Damage during
Angioplasty Results of the ARMYDA-4 Trial
A
prospective randomized controlled study of the Medtronic
Interceptor® PLUS Coronary Filter System for PCI of Degenerative
SVG Results of the AMEthyst Trial
Effect of Distal Embolization on Myocardial Perfusion Reserve
Following Percutaneous Coronary Intervention: A Quantitative MR
Perfusion Study. Joseph
Selvanayagam, M.D.
Patients with ACS undergoing PCI after randomization to Heparin
plus GP IIb/IIIa Inhibitors Vs. Bivalirudin with or whitout GP
IIb/IIIa Inhibitors.
The results of the ACUITY PCI Trial. Harvey White, M.D.
Safety and Efficacy of Bivalirudin in Patients with Non-ST
Elevation ACS undergoing Medical Management.
One Year Results from the ACUITY Trial. Walter Desmet, M.D.
Cardiac Magnetic Resonance in patients with acute MI.
Michael Shapiro, M.D., et al
Long term Follow-up of the Diabetes
I (DIABETes and Sirolimus Eluting Stent) Trial.
Manel Sabate, M.D. et al.
Drug Eluting Stents Vs. Bare Metal Stents in Sweden.
The Results of the SCAAR Trial. Stefan James M.D. et al.
Abciximab Vs. Placebo in Patients with NSTEMI undergoing PCI
Aftrer Pretreatment with Clopidogrel. The ISAR-REACT 2
Trial. The ISAR-REACT 2 Trial. M. Seyfarth
M.D. et al
E
uroHeart
Survey Programme. The EUROASPIRE Surveys.
Professor David A. Wood. et al.
Sirolimus Eluting Stents Vs. Bare Metal Stents Implantation
Assisted by Systematic GP IIb/IIIa Infusion in Patients with MI.
The STRATEGY Trial. Marco Valgimigli M.D.et al
Safety and efficacy of Intravenous Enoxaparin in Eective
Percutaneous Coronary Intervention: An International Randomized
Evalutaion. The STEEPLE Trial. G. Montalescot
M.D. et al.
Efficacy Non-Invasive Ventilation in
Patients with Acute Cardiogenic Pulmonary Edema.
The 3 CPO Trial . David Newby M.D. et al.
Action in Diabetes and Vascular Disease . The ADVANCE Trial.
S. MacMahon et al.
Substudy of Michelangelo: OASIS 5- Women's
Substudy. Eva Swahn M.D.
5-year
Outcome of the German Epidemiological
Trial on Ankle Brachial Index.
The getABI Study. Curt
Diehm, M.D.
Predictor of Response of CRT. The results of the PROSPECT
Study. Cecilia Linde, M.D.
Western Norway B-vitamin Intervention Trial.
The WENBIT Trial. Marta Ebbing, M.D.
Effect of Rosiglitazone on the Risk of Myocardial Infarction And
Death from Cardiovascular Causes. George Diamond M.D. and Sanjay
Kaul M.D.
A
Regionalized Approach to Patients with AMI . The Mayo Clinic
Experience.
Henry Ting M.D.http://clintrialresults.org/Slides/Ting
STEMI Slides.ppt
Prognostic Value of B-Type
Natriuretic Peptides in Patients with stable
Coronary Artery Disease, the Results of the PEACE Trial.
Professor Torbjorn Omland
The FAST Trial .
Femoral Artery Stenting Trial.
Hans Krankenberg M.D.
and
Michael Schlüter, PhD
The EMERALD Trial - Diabetic Substudy
Steve Marso, M.D.
I
mpact
on prior peripheral arterial disease and stroke outcomes of
acute coronary syndromes and effect of evidence-based therapies
(from the GRACE Registry)
Debabrata Mukherjee,
M.D.
Angiographic estimates of myocardium at risk during acute
myocardial infarction: A validation using cardiac MRI
José T. Ortiz M.D.
Long term events in DES: A specific focus on the treatment of
diseased saphenous vein grafts from the randomized
Delayed-RRISC Trial
Pierfrancesco Agostoni M.D. and
Paul Vermeersch M.D.
A Comparison Between Iodixanol and Iopamidol in High Risk
Patients for Contrast Reduced Nephropathy. Results of the CARE
Trial.
Richard Solomon M.D.
Red Cell distribution Width as a Novel Prognostic Marker
in Heart Failure: Data from the CHARM Program and the DUKE
Databank.
Michael Felker, M.D.
The MULTI-STRATEGY Trial. Evaluation of single high-bolus dose
tirofiban Vs. abciximab and SES Vs. BMS in acute MI.
Marco Valgimigli, M.D.
The
GRACE Registry. Combining warfarin after coronary stenting.
Michael Nguyen, M.D.
Natural History of Lone Atrial Fibrillation. 30-year Follow-up
Study.
Paul A. Friedman, M.D.
Infarct Transmurality Size Assessed by Delayed Enhancement MRI:
Time-to-Treatment, ST-Segment Resolution, and TIMI-Flow Grades.
Holger Thiele, M.D.
Impact of Platelet Reactivity Following Clopidogrel
Administration on Drug Eluting Stent Thrombosis. David
Antoniucci, M.D.
|
Slide Library / Menu with Thousands of Slides
Click Here |
Interpreting COURAGE: One Interventional
Cardiologist’s Perspective
Duane S. Pinto, M.D.
The PROGRESS-AMS Study. Clinical
performance and angiographic results of
coronary stenting with Absorbable Metal
Stents. Raimund Erbel, MD.
DEFER STUDY: 5-YEAR FOLLOW-UP
A Multicenter Randomized Study to Compare
Deferral Versus Performance of PCI of
Non-Ischemia-Producing Stenoses. Nico H.J.
Pijls, MD, PhD
PCI in Patients Receiving Enoxaparin or UFH Following
Fibrinolytic Therapy for STEMI:PCI ExTRACT-TIMI 25.
C. Michael Gibson, MD
CHARISMA: The CAPRIE-like Cohort. Deepak Bhatt, MD.
Three Year Result of Intracoronary Stand-alone
Bolus Administration of Eptifibatide During
Coronary Intervention Walid
M. Hassan, MD. Hassan et al. Catheterization and
Cardiovascular Interventions. 2007; 69 (6): S93.
Superiority of 600 mg of Clopidogrel as a Loading Dose: A
MetaAnalysis
Presented at SCAI 07. Biondi-Zoccai and Abbate et al
Clopidogrel Use and Death/MI After Stent Implantation in a
Diabetic Population. Results from the SUNSET Registry.
Somjot Brar MD, et al.
Review and Update for Practitioners: ACS, PCI and CABG in Women.
Jeffrey J. Popma, MD.
Randomized Trial of Sirolimus Stent Vs Bare Metal Stent in Acute
Myocardial Infarction. SESAMI Trial. Mauricio Menichelli,
MD, et al.
Intracoronary Streptokinase After Primary Percutaneous Coronary
Intervention. Murat Sezer, MD, et al.
Impact of DES on Revascularization Choices in Patients with
Acute Coronary Syndromes and Multivessel Coronary Disease:
Results from The CRUSADE Quality Improvement Initiative.
Gogo Prospero M.D., et al.
White Blood Cell Count Secular trend and Mortality: The
Baltimore Longitudinal Study of Aging.
Carmelinda dr.ssa Ruggiero M.D., et al.
Recent Slides
COURAGE Resource Center
COURAGE Clinical Outcomes Utilizing
Revascularization and Aggressive Guideline-Driven Drug
Evaluation. Bill Boden, M.D.
COURAGE Design and Baseline Characteristics
of the COURAGE trial by Bill Boden
Dr. Bill Boden discusses the results of the COURAGE trial on C TV
AVERT
Atorvastatin Versus Revascularization Treatments
PCI vs Conservative Therapy for Chronic CAD Results from
Meta-Analysis 2005
Survival PCI vs Medical Management
The answer may depend on
patient risk
Risk Factor Profiling by Cardiac MRI: Can it be a reality?
Katherine C. Wu, MD.
Long-Term Prognosis Associated with Coronary Calcification
Matthew J. Budoff, MD.
ADHERE: Admission B-Type Natriuretic Peptide Levels and
In-Hospital Mortality in Acute Decompensated Heart Failure
Gregg C. Fonarow MD.
The
CRUSADE National Quality Improvement Initiative:
Characteristics, Management, and Outcomes of 5,557
Patients Age ≥90 Years With Acute Coronary Syndromes. Adam H.
Skolnick, MD.
Evaluation by Optical Coherence Tomography (OCT) of Neointimal
Coverage of Sirolimus-Eluting Stent Three Months After
Implantation Masamichi Takano, MD. et al
Analysis of 36 Reported Cases of Late Thrombosis in Drug-Eluting
Stents Placed in Coronary Arteries. Ramin
Artang, MD and Robert S. Dieter, MD. et al
T
AXUS
ATLAS
WORKHORSE and DIRECT STENT First Report of Nine and
Twelve Month Clinical and Angiographic Results. Mark A. Turco,
MD and John A. Ormiston, MBChB
Randomized Early versus Late AbciXimab in Acute Myocardial
Infarction treated with primary coronary intervention (RELAx-AMI
Trial)
Mauro Maioli, M.D.
Clinical Implications of Clopidogrel non-responsiveness.
Dominick Angiolillo, MD, PhD
Post-Conditioning the Human Heart to Reduce Infarct Size.
Michel Ovize, MD, PhD.
ACUITY 1 Year Results A Prospective, Randomized Trial
of Bivalirudin in Acute Coronary Syndromes Final One-Year
Results from the ACUITY Trial. Gregg W. Stone, MD
Randomized Double Blind Trial of Thrombin Receptor Antagonist (TRA)
Moliterno et al
ARMYDA-ACS: Atorvastatin Pretreatment
Improves Outcome in Patients With Acute Coronary Syndromes
Undergoing Percutaneous Coronary Intervention
TRIUMPH
The Tilarginine Acetate Injection in a Randomized
International Study in Unstable Acute Myocardial Infarction
Patients with Cardiogenic Shock Trial. Judith S. Hochman, M.D.
ARISE
Aggressive Reduction of Inflammation Stops
Events. Presented by Dr. Jean-Claude Tardif
Cardiovascular Risk with COX-IIs - MEDAL Program:
Multinational Etoricoxib and Diclofenac Arthritis
Long-term. Christopher P. Cannon, MD
Aliskiren and Valsartan for Antihypertensive Therapy.
Presented by Dr. Suzanne Oparil
ECLIPSE
Blood Pressure Control with Clevidipine Compared with
Nitroglycerin, Sodium Nitroprusside, or Nicardipine in the
Treatment of Peri-operative Hypertension Solomon Aronson, M.D.
ECLIPSE BP Control Blood Pressure Control
is an Independent Predictor of Short-term Mortality in Cardiac
Surgery Patients. Solomon Aronson, M.D.
RACE:
Reperfusion in AMI in Carolina Emergency Departments.
Christopher Granger, MD.
OASIS 6: Efficacy and safety of fondaparinux in elderly
patients with STEMI. Ron J.G. Peters, MD.
Implications of Preoperative Thienopyridine Use Prior to
Coronary
Bypass Graft Surgery in Patients with ACS:
A Report from the ACUITY Trial. Ramin Ebrahimi, MD.
ANTHEM-TIMI 32: Results of the Dose- Ranging and Heparin
De-Escalation Phases of the ANTHEM-TIMI 32 Trial. Robert P.
Giugliano, MD, SM.
ABSORB First-ever human trial of a fully bioabsorbable
everolimus-eluting stent. Presented by Dr. Patrick W. Serruys
DEDICATION
Distal protection using a Filterwire compared with conventional
intervention among patients with STEMI undergoing PCI. Presented
by Dr. Leif Thuesen.
ERASE Effect of rHDL on Atherosclerosis-Safety and Efficacy.
Presented by Dr. Jean-Claude Tardif.
ILLUSTRATE
Investigation of Lipid Level Management Using Coronary
Ultrasound to Assess Reduction of Atherosclerosis by CETP
Inhibition and HDL Elevation. Presented by Dr. Steven E. Nissen.
METEOR
Measuring Effects of Intima-Media Thickness: An Evaluation of
Rosuvastatin. Presented by Dr. John R. Crouse III.
View an animated presentation.
View other resources
NAPA Nesiritide Administered
Peri-Anesthesia in Patients Undergoing Cardiac Surgery. Mark J.
Russo, MD, MS.
SPIRIT III
Clinical, Angiographic, and IVUS Results from the Pivotal
U.S. Randomized SPIRIT III Trial of the XIENCE V
Everolimus-eluting Coronary Stent System. Gregg W. Stone,
MD.
FUSION
II Follow-Up Serial Infusions of Nesiritide for the
Management of Patients With Heart Failure.
EVEREST
Efficacy of Vasopressin antagonism in hEart failuRE: outcome
Study with Tolvaptan (EVEREST). Marvin A. Konstam, MD
ACC 2007 In Review
Top
Ten Clinical Trials of the Year: 2006
Emerging Data Regarding the Potential Benefits of Early
Initiation of Clopidogrel Among ACS Patients. C. Michael
Gibson, M.S., M.D.
New Approaches to Chronic Anticoagulation: Factor XA Inhibition.
C. Michael Gibson, MS, MD.
LDL or
HDL: Which is More Important?
Christopher P. Cannon, MD
Is It Safe To Switch Between Antithrombins? C. Michael
Gibson, M.S., M.D.
Antiplatelet Therapy in ACS and PCI: Challenges and Future
Directions. Stephen D. Wiviott, MD.
Incorporating Patient Risk into Decisions Regarding the Optimal
Reperfusion Strategy for ST Elevation MI. Duane S. Pinto,
MD.
Appropriate Use of Lytics: Adherence to the Guidelines. W.
Frank Peacock, MD, FACEP.
Pretreatment with Thienopyridines: Emerging Data Regarding
the Potential Benefits of Early Initiation of Clopidogrel Among
ACS Patients. C. Michael Gibson, MS, MD
Targeting Hemoglobin and the Use of Erythropoietin and
Transfusion in Cardiac Patients. Peter A. McCullough, MD,
MPH, FACC, FACP.
Prognostic Implications of Bleeding and Transfusions in Acute
Coronary Syndromes and Percutaneous Coronary Intervention.
Steven V. Manoukian, M.D., F.A.C.C., F.S.C.A.I.
10 Lessons Learned from CRUSADE: Can Rapid Risk
Stratification of Unstable Angina Patients Suppress Adverse
Outcomes with Early Implementation of the ACC and AHA
Guidelines? Eric D. Peterson, MD, FACC.
Coronary Revascularization in Diabetic Patients: Optimizing
Outcomes in 2007. David J. Cohen, M.D., M.Sc.
Effect of Aspirin Dose on Platelet Reactivity in Diabetic
Patients. Paul A. Gurbel, MD.
Are all Xa Inhibitors the Same?
Alexander G. G. Turpie, M.D.
Pay For Performance: What Does it Mean, What will be its Impact
in CV Care. James Hoekstra, MD
Toxicity and Screening Recommendations for Amiodarone Use.
Peter Zimetbaum, MD, FACC.